Home » Topics » BioWorld Science

BioWorld Science
RSS

NEO-PV-01 induces broad and durable immune responses in patients with metastatic cancers

Oct. 30, 2018

Dual GLP-1/GIP agonist LY-3298176 superior to GLP-1 agonist dulaglutide for diabetes control

Oct. 30, 2018

Inhibition of hippocampal TLR2 signaling prevents Alzheimer's disease development

Oct. 30, 2018

MicroRNA-31-5p levels defines disease course and clinical outcome in Crohn's disease

Oct. 30, 2018

New phase Ib/IIa study explores use of AG-019 for treatment of early-onset type 1 diabetes

Oct. 29, 2018

Innovate demonstrates preclinical proof of concept for larazotide in NASH mouse model

Oct. 29, 2018

Qrumpharma develops inhaled agent for nontuberculous mycobacterial infections

Oct. 29, 2018

New phase I trial evaluates TAK-981 in metastatic solid tumors or lymphomas

Oct. 29, 2018

Aduro initiates phase I study of ADU-1604 in metastatic melanoma

Oct. 29, 2018

Genentech presents data on faricimab and ranibizumab PDS in wet AMD

Oct. 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.